Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.

Scientific reports - 15 Jan 2021

Canut María I, Villa Olaya, Kudsieh Bachar, Mattlin Heidi, Banchs Isabel, González Juan R, Armengol Lluís, Casaroli-Marano Ricardo P

Abstract excerpt

Predicting the therapeutic response to ocular hypotensive drugs is crucial for the clinical treatment and management of glaucoma. Our aim was to identify a possible genetic contribution to the response to current pharmacological treatments of choice in a white Mediterranean population with primary open-angle glaucoma (POAG) or ocular hypertension (OH). We conducted a prospective, controlled, randomized, partial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Co-Repressor Proteins

Share to Cross-Over Studies

Share to DNA Copy Number Variations

Share to Genome-Wide Association Study

Share to Glaucoma, Open-Angle

Share to Intraocular Pressure

Source

Open in PubMed Open full text

Identifiers

PMID: 33452295
DOI: 10.1038/s41598-020-80954-2
PMCID: PMC7810753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.PMID 33452295Read ↗

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients.Semantic proximity Read ↗

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacogenomics in ophthalmology.Semantic proximity Read ↗

Interaction of background genetic risk, psychotropic medications, and primary angle closure glaucoma in the UK BiobankSemantic proximity Read ↗

Pharmacogenomics of steroid-induced ocular hypertension: relationship to high-tension glaucomas and new pathophysiologic insightSemantic proximity Read ↗

Genetic diversity and medicinal drug response in eye care.Semantic proximity Read ↗

The impact of genetic factors on the response to migraine therapy.Semantic proximity Read ↗

Rare protein-altering variants in <i>ANGPTL7</i> lower intraocular pressure and protect against glaucomaSemantic proximity Read ↗

Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma.Semantic proximity Read ↗

Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism.Semantic proximity Read ↗

Amlodipine increases risk of primary open angle glaucomaSemantic proximity Read ↗

Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.